Amdocs Limited (NASDAQ:DOX – Get Rating) saw strong trading volume on Monday . 51,171 shares changed hands during mid-day trading, a decline of 92% from the previous session’s volume of 639,914 shares.The stock last traded at $79.92 and had previously closed at $81.81.
Several analysts recently commented on the stock. Citigroup cut their price objective on shares of Amdocs from $93.00 to $90.00 in a research report on Thursday, May 12th. StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 24th. Finally, Oppenheimer reissued a “top pick” rating on shares of Amdocs in a research report on Friday, May 13th.
The company’s 50-day moving average is $82.89 and its 200 day moving average is $78.94. The company has a market capitalization of $10.30 billion, a PE ratio of 17.72, a P/E/G ratio of 1.72 and a beta of 0.70. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.50 and a current ratio of 1.50.
Amdocs (NASDAQ:DOX – Get Rating) last announced its quarterly earnings results on Wednesday, May 11th. The technology company reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.31. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a net margin of 12.76% and a return on equity of 16.78%. During the same quarter last year, the firm posted $1.05 EPS. On average, analysts forecast that Amdocs Limited will post 4.77 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be issued a dividend of $0.395 per share. This represents a $1.58 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date of this dividend is Wednesday, June 29th. Amdocs’s payout ratio is presently 35.43%.
Several hedge funds and other institutional investors have recently made changes to their positions in DOX. Counterpoint Mutual Funds LLC bought a new position in shares of Amdocs in the 4th quarter worth approximately $27,000. Quent Capital LLC bought a new stake in Amdocs during the 4th quarter worth approximately $29,000. Dark Forest Capital Management LP bought a new stake in Amdocs during the 3rd quarter worth approximately $30,000. JFS Wealth Advisors LLC raised its stake in Amdocs by 58.0% during the 1st quarter. JFS Wealth Advisors LLC now owns 425 shares of the technology company’s stock worth $35,000 after acquiring an additional 156 shares during the period. Finally, Meeder Asset Management Inc. bought a new stake in Amdocs during the 1st quarter worth approximately $36,000. 87.09% of the stock is currently owned by hedge funds and other institutional investors.
About Amdocs (NASDAQ:DOX)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers.
See Also
- Get a free copy of the StockNews.com research report on Amdocs (DOX)
- Doximity Stock is an Interesting Healthcare Play
- Atlassian Stock: Taking Another Look
- SunPower Stock is a Value Solar Play
- Where Are Interest Rates Going This Year? A Lot Higher
- The Analysts Rip The Seams Out Of Stitch Fix
Want More Great Investing Ideas?
- 3 Stocks to DOUBLE This Year
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 9 “MUST OWN” Growth Stocks
Receive News & Ratings for Amdocs Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Amdocs and related companies with MarketBeat.com’s FREE daily email newsletter.